Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A neurokinin receptor antagonist undergoing research for the treatment of chemotherapy-induced nausea and vomiting.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word casopitant.

Examples

  • Nano drug ALX-0081 from Ablynx to open up blocked blood vessels coming Non opium pain drug tezampanel can treat acute migraine, says Raptor GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Drug to improve cognition in Alzheimer's patients Lu AE58054 in human studies: Lundbeck US FDA seeks more data on Sanofi-Aventis sleep drug eplivanserin (Ciltyril)

    DWS Full News Feed 2010

  • Merck GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Novartis 'indacaterol (QAB149) to treat COPD needs more data on dosing: US FDA

    DWS Pill Scribe 2009

  • The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the

    CancerConsultants 2009

  • The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the

    CancerConsultants 2009

  • The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the

    CancerConsultants 2009

  • The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the

    CancerConsultants 2009

  • The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the

    CancerConsultants 2009

  • ZUNRISA ™, the proposed trade name for casopitant, is a trademark of the GlaxoSmithKline group of companies.

    WebWire | Recent Headlines 2008

  • (casopitant); the oxidative stress inducer, elesclomol, for metastatic melanoma and the antigen-specific cancer immunotherapeutic, MAGE-A3 ASCI for non-small cell lung cancer and metastatic melanoma.

    WebWire | Recent Headlines 2008

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.